Reported 13 days ago
A new study has found that U.S. minority veterans experience significant inequities in accessing Novo Nordisk's diabetes and weight loss drugs, Ozempic and Wegovy. Black veterans with diabetes are 26% less likely to receive prescriptions for these medications compared to white veterans, while Asian and Native American veterans show similar disparities. The findings highlight systemic issues in healthcare access and underscore the importance of addressing these inequalities in veteran care.
Source: YAHOO